Metoprolol XR in Heart Failure With Normal Ejection Fraction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.
Also called NCT03882710
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 102 participants
- Registry
-
NCT03882710
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT03882710. Randomized; double masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metoprolol XR in Heart Failure With Normal Ejection Fraction
- Acronym
- HFNEF
- Condition
- Diastolic Heart Failure
- Intervention (Drug)
- Metoprolol XR
- Lead sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
Record details
- Record id
cardio:ct-nct03882710- Content hash
412f59f2b6346db2ad9796cfc7752516c7c56a9eb17f409acbb0d26b9dc8f6a4